NYSE:WAT - Waters Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$184.29 -0.29 (-0.16 %)
(As of 12/19/2018 08:26 AM ET)
Previous Close$184.58
Today's Range$182.76 - $187.01
52-Week Range$167.93 - $220.20
Volume529,998 shs
Average Volume548,132 shs
Market Capitalization$13.98 billion
P/E Ratio24.60
Dividend YieldN/A
Beta0.97
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. The company also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. In addition, the company offers thermal analysis, rheometry, and calorimetry instruments, which are used in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for use in various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Receive WAT News and Ratings via Email

Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Current SymbolNYSE:WAT
Previous Symbol
CUSIP94184810
Phone508-478-2000

Debt

Debt-to-Equity Ratio0.61
Current Ratio6.63
Quick Ratio5.93

Price-To-Earnings

Trailing P/E Ratio24.60
Forward P/E Ratio22.86
P/E Growth2.21

Sales & Book Value

Annual Sales$2.31 billion
Price / Sales6.05
Cash Flow$8.9072 per share
Price / Cash Flow20.69
Book Value$28.09 per share
Price / Book6.56

Profitability

EPS (Most Recent Fiscal Year)$7.49
Net Income$20.31 million
Net Margins2.32%
Return on Equity30.68%
Return on Assets13.96%

Miscellaneous

Employees7,000
Outstanding Shares75,750,000
Market Cap$13.98 billion
OptionableOptionable

Waters (NYSE:WAT) Frequently Asked Questions

What is Waters' stock symbol?

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

How will Waters' stock buyback program work?

Waters declared that its board has authorized a stock repurchase program on Tuesday, April 24th 2018, which permits the company to buyback $3,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 18.2% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board of directors believes its shares are undervalued.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) announced its earnings results on Tuesday, October, 23rd. The medical instruments supplier reported $1.92 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.90 by $0.02. The medical instruments supplier earned $578.02 million during the quarter, compared to analyst estimates of $587.43 million. Waters had a net margin of 2.32% and a return on equity of 30.68%. Waters's quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.77 earnings per share. View Waters' Earnings History.

When is Waters' next earnings date?

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, January 22nd 2019. View Earnings Estimates for Waters.

What guidance has Waters issued on next quarter's earnings?

Waters updated its fourth quarter earnings guidance on Tuesday, October, 23rd. The company provided EPS guidance of $2.55-2.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.69. Waters also updated its FY 2018 guidance to $8.00-8.10 EPS.

What price target have analysts set for WAT?

16 brokerages have issued twelve-month price targets for Waters' stock. Their forecasts range from $180.00 to $230.00. On average, they anticipate Waters' share price to reach $205.3450 in the next year. This suggests a possible upside of 11.4% from the stock's current price. View Analyst Price Targets for Waters.

What is the consensus analysts' recommendation for Waters?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 3 sell ratings, 10 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Waters.

Has Waters been receiving favorable news coverage?

Media coverage about WAT stock has trended neutral this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Waters earned a media sentiment score of 0.4 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an impact on the company's share price in the next few days.

Who are some of Waters' key competitors?

Who are Waters' key executives?

Waters' management team includes the folowing people:
  • Mr. Christopher James O'Connell, Chairman & CEO (Age 51)
  • Ms. Sherry L. Buck, Sr. VP & CFO (Age 54)
  • Dr. Michael C. Harrington, Sr. VP of Global Markets (Age 57)
  • Mr. Ian S. King, Sr. VP of Global Products (Age 61)
  • Mr. Eugene G. Cassis, Sr. Advisor (Age 61)

Who are Waters' major shareholders?

Waters' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Vanguard Group Inc (10.19%), BlackRock Inc. (7.41%), Massachusetts Financial Services Co. MA (5.96%), Bank of New York Mellon Corp (6.00%), Baillie Gifford & Co. (3.39%) and Janus Henderson Group PLC (2.76%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Rohit Khanna, Terrence P Kelly, Thomas P Salice and William J Miller. View Institutional Ownership Trends for Waters.

Which institutional investors are selling Waters stock?

WAT stock was sold by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Nomura Asset Management Co. Ltd., Massachusetts Financial Services Co. MA, Acadian Asset Management LLC, Smith Asset Management Group LP, Wells Fargo & Company MN, Renaissance Technologies LLC and Mackenzie Financial Corp. Company insiders that have sold Waters company stock in the last year include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Joann A Reed, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Terrence P Kelly and Thomas P Salice. View Insider Buying and Selling for Waters.

Which institutional investors are buying Waters stock?

WAT stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, Bank of New York Mellon Corp, Select Equity Group L.P., Nordea Investment Management AB, Man Group plc, AQR Capital Management LLC, Commonwealth Bank of Australia and Nuance Investments LLC. View Insider Buying and Selling for Waters.

How do I buy shares of Waters?

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Waters' stock price today?

One share of WAT stock can currently be purchased for approximately $184.29.

How big of a company is Waters?

Waters has a market capitalization of $13.98 billion and generates $2.31 billion in revenue each year. The medical instruments supplier earns $20.31 million in net income (profit) each year or $7.49 on an earnings per share basis. Waters employs 7,000 workers across the globe.

What is Waters' official website?

The official website for Waters is http://www.waters.com.

How can I contact Waters?

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]


MarketBeat Community Rating for Waters (NYSE WAT)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  345 (Vote Outperform)
Underperform Votes:  459 (Vote Underperform)
Total Votes:  804
MarketBeat's community ratings are surveys of what our community members think about Waters and other stocks. Vote "Outperform" if you believe WAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WAT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel